Foundation News
Thrive is the Foundation of Women’s Cancer’s (FWC) monthly newsletter, featuring inspirational stories from survivors, supporters and advocates, opportunities to get involved, upcoming events and education courses.
Highlights and Resources from the National Rural Health Association Conference, May 16-18, 2023
Sunday, May 28, 2023
The Foundation for Women’s Cancer (FWC) recently participated in the National Rural Health Association (NRHA) Annual Conference in San Diego, California. The conference brought together key stakeholders across industries that are serving and learning from residents of rural communities. Some key highlights, including resources from participating organizations with service lines to rural-residing gynecologic cancer patients … Read More
Endometrial Cancer Advocacy: How to get Involved this June
Tuesday, May 23, 2023
The Society of Gynecologic Oncology (SGO), in partnership with patient advocacy groups, is working to secure an endometrial cancer research funding line in the Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP) with $10 million for fiscal year 2024. The CDMRP receives congressional appropriations explicitly for biomedical research in specific, congressionally identified health … Read More
Chemotherapy Drug Shortage: What You Can Do
Tuesday, May 23, 2023
The Society of Gynecologic Oncology (SGO) and Foundation for Women’s Cancer (FWC) have taken a comprehensive approach to mitigating the chemotherapy shortages and exploring opportunities to prevent drug shortages from occurring in the future. What You Can Do: Endorse the rapid communications regarding treatment options to preserve drug supply and alternative chemotherapy drug guidelines if … Read More
A Message to Our Gynecologic Cancer Patients, Advocates, and Community
Wednesday, April 26, 2023
The American Society of Health-System Pharmacists and Food and Drug Administration (FDA) recently reported a U.S. shortage of several drugs, including cisplatin, carboplatin, and methotrexate. These chemotherapy drugs are used to treat many types of gynecologic cancers, such as those involving the uterus, cervix, ovaries, and fallopian tubes. The Foundation for Women’s Cancer (FWC), alongside … Read More
FWC Awards $628,500 in Research Grants & Awards in 2022-2023
Sunday, March 26, 2023
The Foundation for Women’s Cancer (FWC) is pleased to announce the winners of its 2022-2023 FWC research grants and awards. The FWC Research Grants and Awards Program strives to accelerate the research of young investigators and promote the long-term success of the gynecologic oncology field. Importantly, as of March 2023, more than $10 million has been … Read More
